Ascend Wellness Holdings, Inc. (AAWH)
(Delayed Data from OTC)
$1.07 USD
+0.03 (2.88%)
Updated Jul 26, 2024 03:48 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Ascend Wellness Holdings, Inc. (AAWH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.70 | $6.00 | $2.50 | 255.77% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Ascend Wellness Holdings, Inc. comes to $3.70. The forecasts range from a low of $2.50 to a high of $6.00. The average price target represents an increase of 255.77% from the last closing price of $1.04.
Analyst Price Targets (5 )
Broker Rating
Ascend Wellness Holdings, Inc. currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.60 a month ago based on five recommendations.
Of the six recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 66.67% and 16.67% of all recommendations. A month ago, Strong Buy made up 60%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.60 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/23/2024 | Seaport Research Partners | Sonny Randhawa | Strong Buy | Strong Buy |
7/16/2024 | PI Financial Corp. | Andrew Semple | Not Available | Strong Buy |
4/25/2024 | ATB Capital Markets | Frederico Gomes | Strong Buy | Strong Buy |
3/1/2024 | Cormark Securities | Jesse Pytlak | Moderate Buy | Moderate Buy |
2/16/2024 | Needham & Company | Matthew R Mcginley | Hold | Hold |
2/2/2024 | Haywood Securities | Neal Gilmer | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 6 |
Average Target Price | $3.70 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | -0.08 |